X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
1st-line treatment (2) 2
antibodies (2) 2
cancer (2) 2
chemotherapy (2) 2
docetaxel (2) 2
immunotherapy (2) 2
index medicus (2) 2
lung cancer, non-small cell (2) 2
oncology (2) 2
viral antibodies (2) 2
aged (1) 1
analysis (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
anticancer agents (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bevacizumab (1) 1
cancer therapies (1) 1
carboplatin - administration & dosage (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
care and treatment (1) 1
checkpoint inhibitors (1) 1
cisplatin (1) 1
combination drug therapy (1) 1
controlled-trial (1) 1
cytotoxicity (1) 1
double-blind (1) 1
female (1) 1
hematology, oncology and palliative medicine (1) 1
humans (1) 1
ipilimumab (1) 1
lung cancer (1) 1
lung neoplasms - drug therapy (1) 1
male (1) 1
middle aged (1) 1
multicenter (1) 1
nivolumab (1) 1
nivolumab plus ipilimumab (1) 1
non-small-cell lung carcinoma (1) 1
open-label (1) 1
pembrolizumab (1) 1
pemetrexed - administration & dosage (1) 1
pharmaceutical industry (1) 1
phase-3 (1) 1
respiratory system (1) 1
studies (1) 1
survival (1) 1
therapy (1) 1
tremelimumab (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1497 - 1508
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.